Revolution Medicines, Inc. (NASDAQ:RVMDW) Short Interest Update

Revolution Medicines, Inc. (NASDAQ:RVMDW) was the recipient of a large increase in short interest during the month of February. As of February 27th, there was short interest totaling 1,369 shares, an increase of 138.9% from the February 12th total of 573 shares. Based on an average daily trading volume, of 11,580 shares, the days-to-cover ratio is presently 0.1 days. Based on an average daily trading volume, of 11,580 shares, the days-to-cover ratio is presently 0.1 days.

Revolution Medicines Stock Performance

Shares of Revolution Medicines stock opened at $1.64 on Friday. The business has a 50 day moving average of $2.02 and a 200 day moving average of $1.02. Revolution Medicines has a 52 week low of $0.03 and a 52 week high of $3.59.

Revolution Medicines Company Profile

Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.

Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.